Dr Reddys Laboratories Ltd Share Price Today - Live Blog for April 28, 2026

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 1.55% increase and currently trading at 1355.20 per share. Investors are taking notice of this upward momentum.

Dr Reddys Laboratories Ltd's share price rallied by 1.27%, reaching the current market price of 1351.40. This surge is indicative of the stock's recent positive performance.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 1.27% increase and currently trading at 1351.40 per share. Investors are taking notice of this upward momentum.

After a notable 2.25% increase, Dr Reddys Laboratories Ltd's shares are now trading at 1364.50. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1625 and an ROE of 16.0277.

The share price of Dr Reddys Laboratories Ltd recently experienced a positive upturn, resulting in a 2.25% increase. Presently, it is actively trading at 1364.50.

Dr Reddys Laboratories Ltd share price surged by 1.84%. With its current market price standing at 1359.00 per share, this stock is garnering increased attention from the investment community.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 1.84% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1359.00 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 1.85%, reaching the current market price of 1359.20. This ascent signifies increased investor sentiment. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.

Investors are buzzing as Dr Reddys Laboratories Ltd's share price soared by an impressive 1.85%. At this moment, it's actively trading at 1359.20, presenting an enticing opportunity for those in the market.

Dr Reddys Laboratories Ltd witnessed a notable 0.44% surge in its share price and is presently trading at 1340.40, captivating the attention of market participants.

In a noteworthy development, Dr Reddys Laboratories Ltd witnessed a remarkable 0.44% increase in its share price. This surge in value has sparked heightened investor interest, with the stock currently trading at 1340.40 per share. The stock has an ROE of 16.0277 and debt to equity ratio of 0.1625.